Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation.
Masaoka
T
T
Center for Adult Disease, Osaka, Japan.
Takaku
F
F
Kato
S
S
Moriyama
Y
Y
Kodera
Y
Y
Kanamaru
A
A
Shimosaka
A
A
Shibata
H
H
Nakamura
H
H
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D003115:Colony-Stimulating Factors / Q000009:adverse effects / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000517:prevention & control; D016179:Granulocyte Colony-Stimulating Factor; D006098:Granulocytes / Q000187:drug effects; D006801:Humans; D007223:Infant; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence
D003115:Colony-Stimulating Factors; D003524:Cyclosporins; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D008727:Methotrexate